AUA 2025 Prostate Cancer

Viewing 1-20 of 42 articles

AUA 2025: A Novel Core Needle Biopsy Instrument Designed for Targeted Biopsy

AUA 2025: Impact of Prior Holmium Laser Enucleation of the Prostate (HoLEP) on the Accuracy of PI-RADS for Assessing Clinically Significant Prostate Cancer

AUA 2025: Rizedisben, a Novel Myelin-Binding Fluorophore for Intraoperative Fluorescent Imaging of Nerve Structures: Phase I Trial in Robotic Radical Prostatectomy

AUA 2025: State-Of-The-Art Lecture: A Perfect Storm: The Timing, Scope, and Spectrum of Radiation-Induced Complications after Prostate Cancer Treatment

AUA 2025: Safety of Stabilized Hyaluronic Acid as a Rectal Spacer: Low Risk of Rectal Wall Infiltration and Reversibility

AUA 2025: Ultra-low PSA Response (0.02 ng/mL) with Darolutamide Plus ADT in ARANOTE Correlates with Greatly Improved Clinical Outcomes

AUA 2025: Comparison of Cardiovascular Events in Patients with Advanced Prostate Cancer treated with LHRH Agonists versus Antagonists in the US: An Analysis of the TriNetX Database

AUA 2025: Health-Related Quality of Life, Pain and Safety Outcomes in the Phase 3 PSMAfore Study of 177Lu-PSMA-617 in Patients with mCRPC

AUA 2025: Prespecified Third Interim Analysis of the Darolutamide Observational (DAROL) Study in Patients with nmCRPC: North American Subgroup Analysis

AUA 2025: Real World Treatment Patterns and Outcomes in Patients with mCRPC Treated in Community Urology Centers in the US: A Cohort Study Using the PRECISION Data Platform

AUA 2025: The Role of PSMA-Radioguided Surgery in Identifying Tumor Locatino and Local Staging in Prostate Cancer Patients Undergoing Radical Prostatectomy And Extended Lymph Node Dissection. Interim Analysis of Phase 2 Study

AUA 2025: Biochemical Recurrence Management in 2025 – High-Yield Take Home Messages for the Practicing Clinician

AUA 2025: Testosterone Recovery Profiles after Cessation of Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis of Prospective Trials

AUA 2025: Assessing the Optimal Duration of Androgen Deprivation Therapy in Node Positive Patients Receiving Postoperative Radiotherapy: Applicability of the RADICALS-HD

AUA 2025: Which Are the Prognostic Implications of a Negative PSMA-PET at the Time of Biochemical Recurrence in Prostate Cancer Patients Treated With Radical Prostatectomy? Selection of Salvage Therapies Candidates

AUA 2025: Impact of Previous Pelvic Radiotherapy on PSMA PET Outcomes in Patients Experiencing Biochemical Recurrence after Radical Prostatectomy. Implications for Optimal Timing of Restaging

AUA 2025: Metastatic Hormone Sensitive Prostate Cancer – So Many Randomized Trials (Nine), yet Monotherapy Treatment Persists

AUA 2025: PSMA-Targeted Actinium-225 Therapy in Metastatic Castration-Resistant Prostate Cancer: Comparative Outcomes Between Monotherapy vs. Combination Therapy

AUA 2025: Sub-Classification of CHAARTED and LATITUDE Risk Categories: Analysis of the Discrepancy Between High- and Low- Groups: A Multicenter Retrospective Study

AUA 2025: Systemic Treatment Prescription and Switch Patterns in mHSPC Based on Real World Evidence: Results from the PIONEER+ Big Data Consortium for Prostate Cancer

1
2
3